Skip to main content

Remote Job Finders (RJF)

Amgen shores up Tavneos’ FDA defense with Duke data analysis

After the FDA flagged patient deaths linked to Amgen’s rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independent data analysis from Duke researchers to help build the case for the drug’s continued market approval.

Novo hit with cybersecurity breach, urges vigilance among trial participants

Novo Nordisk said that the information affected by the breach shouldn’t allow third parties to “identify participants in our clinical trials” despite “unauthorized access” to patients’ personal data.
Scroll to top